2024conference-paper

Impaired xenon gas transfer observed one year after hospitalisation due to COVID-19 in patients with signs of interstitial lung disease.

Laura Saunders, Guilhem Collier, Ho‐Fung Chan, Paul Hughes, Laurie Smith, Neil J. Stewart, Jonathan Brooke, James Watson, James Meiring, Zoë Gabriel, Tom Newman, Megan Plowright, Phillip Wade, James Eaden, Jody Bray, Helen Marshall, David Capener, Leanne Armstrong, Jennifer Rodgers, Martin Brook, Alberto Biancardi, Madhwesha Rao, Graham Norquay, Oliver Rodgers, Ryan Munroe, James Ball, Gísli Jenkins, James T. Grist, Kher Lik Ng, Ling‐Pei Ho, Fergus Gleeson, Ian P. Hall, Thomas Meersmann, Galina E. Pavlovskaya, Arthur Harrison, Joseph Jacob, Andrew J. Swift, Smitha Rajaram, Gary L. Mills, Lisa Watson, Paul Collini, Rod Lawson, A. A. Roger Thompson, Jim M. Wild

0Citations signalées

0Institutions associées

0Pays d’affiliation

Résumé fourni par la source

Patients with signs of interstitial lung disease at 12 weeks after hospitalisation due to COVID-19 underwent 1H and 129Xe MRI. 129Xe MRI showed impaired xenon gas transfer (RBC:M and RBC:gas) at 24 and 52 weeks after hospital admission, with no longitudinal change between 24 and 52 weeks observed in 129Xe MRI metrics or PFT transfer factor. Xenon MRI metrics correlated significantly with PFT transfer factor at 24 weeks (RBC:M, RBC:gas, LmD) and 52 weeks (RBC:M, RBC:gas, LmD).

Sujets associés

Atomic and Subatomic Physics ResearchAdvanced MRI Techniques and ApplicationsMedical Imaging Techniques and Applications

Voir la notice officielle DOI